Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by Millennium Management LLC

Millennium Management LLC lowered its position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 43.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 772,922 shares of the company's stock after selling 582,899 shares during the quarter. Millennium Management LLC owned 0.67% of Definitive Healthcare worth $3,177,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Nisa Investment Advisors LLC increased its holdings in shares of Definitive Healthcare by 3,652.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company's stock valued at $29,000 after purchasing an additional 6,794 shares in the last quarter. Bayesian Capital Management LP purchased a new stake in shares of Definitive Healthcare during the fourth quarter worth about $41,000. Ieq Capital LLC acquired a new position in Definitive Healthcare during the fourth quarter worth approximately $51,000. KLP Kapitalforvaltning AS acquired a new position in Definitive Healthcare during the fourth quarter worth approximately $54,000. Finally, Two Sigma Securities LLC acquired a new position in Definitive Healthcare during the fourth quarter worth approximately $56,000. Hedge funds and other institutional investors own 98.67% of the company's stock.

Wall Street Analysts Forecast Growth

DH has been the subject of several research analyst reports. Wall Street Zen lowered shares of Definitive Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday. The Goldman Sachs Group upped their price target on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a "neutral" rating in a research report on Monday, May 12th. BTIG Research lowered shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Finally, Barclays dropped their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set an "underweight" rating for the company in a research report on Monday, March 3rd. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $5.10.

Definitive Healthcare Trading Up 1.7%

Shares of Definitive Healthcare stock traded up $0.06 during trading hours on Wednesday, hitting $3.55. The company's stock had a trading volume of 516,418 shares, compared to its average volume of 813,105. Definitive Healthcare Corp. has a 1-year low of $2.15 and a 1-year high of $6.27. The business has a fifty day moving average of $2.89 and a 200 day moving average of $3.75. The company has a market capitalization of $527.68 million, a PE ratio of -1.15, a P/E/G ratio of 4.06 and a beta of 1.48. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company had revenue of $59.19 million during the quarter, compared to analyst estimates of $56.20 million. During the same quarter in the prior year, the business earned $0.08 earnings per share. The business's quarterly revenue was down 6.8% compared to the same quarter last year. As a group, equities analysts forecast that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.